Classic Kaposi Sarcoma — Trials

Classic Kaposi Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05846724	Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma(PULSAR)	withdrawn	Phase 2	0	Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER	0	Jan 22, 2026	clinicaltrials
NCT00521092	Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma	withdrawn	Phase 2	0	National Cancer Institute (NCI)NIH	0	May 5, 2014